India Over the Counter (OTC) Drug market stood at USD4666.15 Million in 2022 and is expected to grow at a steady CAGR of 7.85% during the forecast period. The over the counter (OTC) drug market is driven by growing geriatric population suffering from various diseases. Additionally, prevalence of disease among the youth due to their everyday lifestyles is a major factor that drives this segmental growth. Furthermore, easy availability, affordability, and increased awareness among patients about these over the counter (OTC) drugs are the major drivers that are driving the production of newer and more efficient over the counter (OTC) drugs in India. This in turn is anticipated to positively impact the market growth.

Furthermore, over the counter (OTC) drug manufacturers are more aware about the need for accessible health solutions among people due to the unhealthy dietary habits and thus making drug more efficient, reliable and affordable. They are coming up with new formulations that are designed to cope along with the busy lifestyle treating the patient to the maximum and thereby gaining the consumer trust and reliance for the Over the Counter (OTC) drug market. The digital availability of the over the counter (OTC) drugs with the penetration of online pharmacies is a booster for the over the counter (OTC) drug market as it helps users and make things easier for him/her to and thereby increasing the over the counter (OTC) drug market.

Increasing Awareness for Self-Medication Drives Market Growth

Self-medication is the practice of taking medications, to treat self-diagnosed symptoms, without getting a Doctor’s prescription otherwise on one's own initiative or on the recommendation of another individual. Easy access, availability and awareness are nowadays the most common reason behind practicing self-medication. Self-medication is being practiced frequently ~53.57% (according to a survey by a journal of National `Library of Medicine) in India and is practiced most among the middle-class family. This self-medication trend is anticipated to drive the cough and cold, gastrointestinal, analgesics, multivitamins and dermatological segment of the Over The Counter (OTC) Drugs in the country. The most frequent usage of Over The Counter (OTC) Drugs is in Fever, Headaches, Toothache ,acne, constipation, Musculoskeletal pains  and Cold, Cough & Flu. People are more relaying on this self-medication as it is time saving, often based on previous recommendation as well as the need for faster relief thus driving the market growth by increasing dependency and reach for the Over The Counter (OTC) Drug Market.

Rise in Disease Prevalence among the Elderly are Increasing the Market Demand

The increase of disease prevalence among the growing elderly geriatric population is a measure that is expanding the Over The Counter (OTC) Drug market demand. The dependency on several Over The Counter (OTC) products like Laxatives, Cold, Cough and Flu along with mild analgesics and pain reliever ointments for the geriatric population, is a major reason for the increased demand. Nowadays, due to rising frequency of several old age health issues many Over The Counter (OTC) drugs such as pain reliever and ointments are directly related to their comfort and independency for carrying their everyday lifestyle, thus indirectly maintaining the continuous demand and thus expanding their Over The Counter (OTC) Drug market.  

Increasing cases of Cough Cold & Flu, Body aches and various other Recurring Health Issues in India, demands the Over the Counter (OTC) Drug market.

During the pandemic the increased prevalence of Cold Cough, Fever, Body aches  and severe other similar symptoms along with the fear of contracting the virus  had led to increased demand of these Over The Counter drugs .These Over The Counter (OTC) Drugs as a means for need of  self-medication and as preventing measure is automatically shifting the demand towards the India Over The Counter (OTC) Drug market. Easily accessible drugs in pharmacies such as analgesics, antibiotics, anti-diarrheal agents, antipyretics, cough-suppressants, Vitamins & Mineral supplements (VMS) being cost efficient and having preventive effects during the pandemic were most in demand thus boosting the Over The Counter (OTC) Drug Market.

Launch of New & Updated Customer Centric products accelerates growth of Over The Counter (OTC) Drug Market.

Launching updated products of new formulations of various traditional Over The Counter (OTC) drugs such as alcohol, dye free, honey containing cough or cold oral liquids, sedative free cold and cough formulations, Raft forming oral suspensions, oral and topical analgesics, naturally extracted acne treatment creams and lotions is gaining customers faith for lesser side effects and more consumption thereby increasing the market demand. Also, the usage of various Vitamins and Minerals Supplements (VMS) in distinct formulations brings more to the health-conscious community thus gaining more traction toward the Over The Counter (OTC) Drug market. Also, along with the user’s choice mostly in the dermatology and Vitamins and minerals Supplements (VMS) segment has reached out reliance and popularity on the online consumers thus foreseeing for a boost in the upcoming future of the Over The Counter (OTC) Drug market. Due to online traction for the many Over The Counter (OTC) Drugs


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The India Over The Counter (OTC) Drug market is segmented based on type of Product, Dosage form, Distribution channel and region distribution. Based on type of Product, the market can be categorized into Cold, Cough & Flu, Vitamins, Minerals & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products and Others. By Route of Administration the market can be segmented into Oral, Parenteral, Topical and Others. Based on the Dosage form, the market can be categorized into Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments and Others. Based on Distribution channel, the market is divided into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. In terms of Distribution among region the market can be categorized into West, North, South and East.

Company Profiles

Cipla Limited, Sun Pharmaceuticals Limited, Lupin Limited, GlaxoSmithKline Consumer Healthcare Limited, Dabur India Limited, Abbott India Limited, Dr. Reddy's Laboratories Limited, Emami Limited, Reckitt Benckiser (India) Ltd, Johnson & Johnson Limited, are among the major market players in the Indian platform that lead the market growth of the India Over The Counter (OTC) Drug market.

Attribute

Details

Market size value in FY2022

USD 4666.15 Million

Revenue Forecast in FY2028

USD 7631.78 Million

Growth Rate

7.85%

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Product Type

·         Route of Administration

·         Dosage Form

·         Distribution Channel

Regional Scope

West; South; North; East.

Key Companies Profiled

Cipla Limited, Sun Pharmaceuticals Limited, Lupin Limited, GlaxoSmithKline Consumer Healthcare Limited, Dabur India Limited, Abbott India Limited, Dr. Reddy's Laboratories Limited, Emami Limited, Reckitt Benckiser (India) Ltd, Johnson & Johnson Limited.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, India Over The Counter (OTC) drug market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Over The Counter (OTC) Drug Market, By Type of Product:
    • Cold, Cough & Flu
    • Vitamins, Minerals & Supplements (VMS)
    • Analgesics
    • Gastrointestinal Products
    • Dermatology Products
    • Others
  • India Over The Counter (OTC) Drug Market, By Route of Administration:
    • Cold, Cough & Flu
    • Vitamins, Minerals & Supplements (VMS)
    • Analgesics
    • Gastrointestinal Products
    • Dermatology Products
    • Others
  • India Over The Counter (OTC) Drug Market, By Route of Administration:
    • Oral
    • Parenteral
    • Topical
    • Others
  • India Over The Counter (OTC) Drug Market, By Dosage Form:
    • Tablets
    • Capsules
    • Liquids & Solutions
    • Cream/Lotion/Ointments
    • Others
  • Over The Counter (OTC) Drug Market, By Type of Distribution Channel:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • Wheelchair Market, By Region:
    • West
    • South
    • North
    • East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India Over The Counter (OTC) Drug market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on India Over The Counter (OTC) drug Market

5.    Voice of Customer

5.1.  Brand Awareness

5.2.  Demand, By Product Type

5.3.  Preferred Mode of Purchase

5.4.  Source of Information

6.    India Wheelchair Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     Market Share & Forecast

6.2.2.     By Product (Cold, Cough & Flu, Vitamins, Minerals & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others)

6.2.3.     By Route of Administration (Oral, Parenteral, Topical, Others)

6.2.4.     By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others)

6.2.5.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.6.     By Region

6.2.6.1.         By State (Top 3 States)

6.2.7.         By Company (2022) 

6.3.  Product Market Map

7.    West India Over the Counter (Over The Counter (OTC)) Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1. By Value

7.2.  Market Share & Forecast

7.2.1. By Product

7.2.2. By Route of Administration

7.2.3. By Dosage Form

7.2.4. By Distribution Channel

8.    South India Over the Counter (Over The Counter (OTC)) Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1. By Product

8.2.2. By Route of Administration

8.2.3. By Dosage Form

8.2.4. By Distribution Channel

9.    North India Over the Counter (Over The Counter (OTC)) Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1. By Product

9.2.2. By Route of Administration

9.2.3. By Dosage Form

9.2.4. By Distribution Channel

10.  East India Over the Counter (Over The Counter (OTC)) Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.    By Product

10.2.2.    By Route of Administration

10.2.3.    By Dosage Form

10.2.4.    By Distribution Channel

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  Import-Export Analysis

15.  India Economic Profile

16.  Competitive Landscape

16.1.              Cipla Limited

16.2.              Sun Pharmaceuticals Limited

16.3.              Lupin Limited

16.4.              GlaxoSmithKline Consumer Healthcare Limited

16.5.              Dabur India Limited

16.6.              Abbott India Limited

16.7.              Dr. Reddy's Laboratories Limited

16.8.              Emami Limited

16.9.              Reckitt Benckiser (India) Ltd

16.10.            Johnson & Johnson Limited.

17.  Strategic Recommendations

18.  About us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com
  • List of Figures:

    Figure 1: India Over The Counter (OTC) Drug Market Size, By Value (USD Million), 2018-2028F
    Figure 2:  India Over The Counter (OTC) Drug Market Share, By Product Type, By Value, 2018-2028F
    Figure 3:  India Over The Counter (OTC) Drug Market Share, By Route of Administration, By Value, 2018-2028F
    Figure 4: India Over The Counter (OTC) Drug Market Share, By Dosage form, By Value, 2018-2028F
    Figure 5: India Over The Counter (OTC) Drug Market Share, By Distribution Channel, By Value, 2018-2028F
    Figure 6: India Over The Counter (OTC) Drug Market Share, By Region, By Value, 2018-2028F
    Figure 7: India Over The Counter (OTC) Drug Market Share, By Company, By Value, 2022
    Figure 8: India Over The Counter (OTC) Drug Market Map, By Product Type, Market Size (USD Million) & Growth Rate (%), 2022
    Figure 9: India Over The Counter (OTC) Drug Market Map, By Route of Administration, Market Size (USD Million) & Growth Rate (%), 2022
    Figure 10: India Over The Counter (OTC) Drug Market Map, By Dosage form, Market Size (USD Million) & Growth Rate (%), 2022
    Figure 11:  India Over The Counter (OTC) Drug Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2022
    Figure 12: India Over The Counter (OTC) Drug Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
    Figure 13: West India Over The Counter (OTC) Drug Market Size, By Value (USD Million), 2018-2028F
    Figure 14:  West India Over The Counter (OTC) Drug Market Share, By Product Type, By Value, 2018-2028F
    Figure 15: West India Over The Counter (OTC) Drug Market Share, By Route of Administration, By Value, 2018-2028F
    Figure 16: West India Over The Counter (OTC) Drug Market Share, By Dosage form, By Value, 2018-2028F
    Figure 17: West India Over The Counter (OTC) Drug Market Share, By Distribution Channel, By Value, 2018-2028F
    Figure 18: South India Over The Counter (OTC) Drug Market Size, By Value (USD Million), 2018-2028F
    Figure 19: South India Over The Counter (OTC) Drug Market Share, By Product Type, By Value, 2018-2028F
    Figure 20:  South India Over The Counter (OTC) Drug Market Share, By Route of Administration, By Value, 2018-2028F
    Figure 21: South India Over The Counter (OTC) Drug Market Share, By Dosage form, By Value, 2018-2028F
    Figure 22: South India Over The Counter (OTC) Drug Market Share, By Distribution Channel, By Value, 2018-2028F
    Figure 23: North India Over The Counter (OTC) Drug Market Size, By Value (USD Million), 2018-2028F
    Figure 24: North India Over The Counter (OTC) Drug Market Share, By Product Type, By Value, 2018-2028F
    Figure 25: North India Over The Counter (OTC) Drug Market Share, By Route of Administration, By Value, 2018-2028F
    Figure 26: North India Over The Counter (OTC) Drug Market Share, By Dosage form, By Value, 2018-2028F
    Figure 27:  North India Over The Counter (OTC) Drug Market Share, By Distribution Channel, By Value, 2018-2028F
    Figure 28: East India Over The Counter (OTC) Drug Market Size, By Value (USD Million), 2018-2028F
    Figure 29: East India Over The Counter (OTC) Drug Market Share, By Product Type, By Value, 2018-2028F
    Figure 30: East India Over The Counter (OTC) Drug Market Share, By Route of Administration, By Value, 2018-2028F
    Figure 31: East India Over The Counter (OTC) Drug Market Share, By Dosage form, By Value, 2018-2028F
    Figure 32: East India Over The Counter (OTC) Drug Market Share, By Distribution Channel, By Value, 2018-2028F